BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Announced Today the Stock is Halted
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- AI stocks lift Wall St as oil falls, Treasury yields decline
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips briefly below $100 on Saudi exports, hopes of US-Iran diplomacy
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- AMD stock jumps as chip rally builds ahead of summit
BioMarin Pharma (BMRN) will resume trading at 7:10am ET
November 25, 2015 6:53 AM ESTBioMarin Pharma (NASDAQ: BMRN) will resume trading at 7:10am EST.
... MoreBioMarin Pharma (BMRN) Affirms Trading Halt Ahead of FDA Committee Review of Kyndrisa NDA
November 24, 2015 7:08 AM ESTBioMarin Pharma (NASDAQ: BMRN) announced today that NASDAQ has halted trading of the companys stock. The Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) of the U.S. Food and Drug Administration (FDA) is meeting today to review BioMarins New Drug Application... More
